Business Context and Reporting Period
This Form 8-K is a current report filed by Data Knights Acquisition Corp. (the "Company") on July 31, 2023. The Company is a Special Purpose Acquisition Company (SPAC) incorporated in Delaware and listed on The Nasdaq Stock Market. The filing announces a special meeting of stockholders scheduled for August 11, 2023, to vote on extending the deadline to consummate a business combination with OneMedNet Corporation ("OMN").
Key Financial Metrics
The filing does not contain audited financial statements, revenue, profit, or cash flow data for the Company or OMN. The only specific financial figures disclosed relate to the proposed extension of the business combination deadline:
- Extension Payment: The Sponsor (Data Knights, LLC) must deposit the lesser of $75,000 or $0.045 per share for each Public Share outstanding for each one-month extension.
- Extension Duration: The proposal allows for up to nine (9) one-month extensions, moving the termination date from August 11, 2023, to May 11, 2024.
- Warrant Exercise Price: Redeemable Warrants are exercisable at $11.50 per share.
Material Changes and Proposals
The primary material event is the proposal to amend the Company's Certificate of Incorporation and Investment Management Trust Agreement to extend the deadline for completing the merger with OMN. Key details include:
- Current Deadline: August 11, 2023.
- Proposed Extended Deadline: May 11, 2024.
- Extension Mechanism: A series of up to nine one-month extensions, contingent on the Sponsor making the required deposit into the Trust Account.
- Adjournment Proposal: If votes are insufficient to approve the extension, the meeting may be adjourned to solicit further proxies.
Outlook, Risks, and Management Commentary
Management states the purpose of the extension is to allow additional time and lower incremental costs to complete the proposed business combination with OMN. The filing includes extensive forward-looking statements and risk factors, including:
- Transaction Completion Risk: The risk that the merger may not be completed in a timely manner or at all.
- Financing Risk: The risk that the Company may not be able to raise third-party financing to meet the "Minimum Cash Condition" if significant share redemptions occur.
- Regulatory and Legal Risk: Potential legal proceedings or changes in laws that could disrupt the transaction.
- Operational Risk: Risks related to OMN's ability to execute its strategic initiatives and the combined company's ability to manage growth.
The filing explicitly states it does not constitute an offer to sell securities or a solicitation of a vote, directing investors to the definitive proxy statement for full details.
Investor Verification Checklist
- Verify the final vote count for the extension proposal at the August 11, 2023, special meeting.
- Confirm the number of Public Shares outstanding to calculate the exact Sponsor deposit required for the extension.
- Review the definitive proxy statement for details on the "Minimum Cash Condition" and potential financing requirements.
- Monitor OMN's financial performance and operational updates, as the filing contains no current financial data for the target company.
- Check for any updates regarding the status of the Business Combination Agreement dated April 25, 2022.